Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Clinical trial NCT00007189 · COMPLETED

Trial details

NCT number: NCT00007189
Sponsor: Seattle Institute for Biomedical and Clinical Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2001-01-01
Primary completion: 2007-05-01
Enrollment: 2625

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.